{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:04:53Z","timestamp":1790060693820,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11916-023-01116-3","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T08:02:35Z","timestamp":1682064155000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low-Dose Initiation of Buprenorphine: A Narrative Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-6206","authenticated-orcid":false,"given":"Amber N.","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar H.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah J.","family":"Spillers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa R.","family":"Zaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey J.","family":"De Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"1116_CR1","unstructured":"Kumar R, Viswanath O, Saadabadi A. Buprenorphine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2023 Jan 22]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459126\/."},{"issue":"1","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1186\/s12913-019-4751-4","volume":"19","author":"KA Hoffman","year":"2019","unstructured":"Hoffman KA, Ponce Terashima J, McCarty D. Opioid use disorder and treatment: challenges and opportunities. BMC Health Serv Res. 2019;19(1):884.","journal-title":"BMC Health Serv Res"},{"key":"1116_CR3","doi-asserted-by":"crossref","unstructured":"Edinoff A, Murnane K, Rosa C, Giepert S, Cornett E, Kaye D, et al. Physiologic considerations in opioid addiction. In: Substance use and addiction research. 1st ed. Academic Press Inc.; 2023. p. 204\u201310.","DOI":"10.1016\/B978-0-323-98814-8.00029-9"},{"issue":"6","key":"1116_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/01.NAJ.0000668736.80609.4e","volume":"120","author":"KG Brown","year":"2020","unstructured":"Brown KG, Capili B. The pathophysiology of and nursing interventions for opioid use disorder. Am J Nurs. 2020;120(6):38\u201346.","journal-title":"Am J Nurs"},{"issue":"2","key":"1116_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.molmed.2017.12.010","volume":"24","author":"V Milivojevic","year":"2018","unstructured":"Milivojevic V, Sinha R. Central and peripheral biomarkers of stress response for addiction risk and relapse vulnerability. Trends Mol Med. 2018;24(2):173\u201386.","journal-title":"Trends Mol Med"},{"issue":"2 Suppl","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","volume":"70","author":"SL Walsh","year":"2003","unstructured":"Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(2 Suppl):S13-27.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"J Bell","year":"2020","unstructured":"Bell J, Strang J. Medication treatment of opioid use disorder. Biol Psychiatry. 2020;87(1):82\u20138.","journal-title":"Biol Psychiatry"},{"issue":"373","key":"1116_CR8","doi-asserted-by":"publisher","first-page":"n784","DOI":"10.1136\/bmj.n784","volume":"19","author":"M Buresh","year":"2021","unstructured":"Buresh M, Stern R, Rastegar D. Treatment of opioid use disorder in primary care. BMJ. 2021;19(373):n784.","journal-title":"BMJ"},{"issue":"4","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/pm\/pnz356","volume":"21","author":"L Webster","year":"2020","unstructured":"Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, et al. Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med. 2020;21(4):714\u201323.","journal-title":"Pain Med"},{"issue":"6","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.dadr.2023.100133","volume":"1","author":"C Heidbreder","year":"2023","unstructured":"Heidbreder C, Fudala PJ, Greenwald MK. History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder. Drug Alcohol Depend Rep. 2023;1(6):100133.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"3","key":"1116_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bpa.2020.06.005","volume":"34","author":"I Urits","year":"2020","unstructured":"Urits I, Pham C, Swanson D, Berardino K, Bandi P, Amgalan A, et al. The utilization of buprenorphine in chronic pain. Best Pract Res Clin Anaesthesiol. 2020;34(3):355\u201368.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/dar.13394","volume":"41","author":"D Shearer","year":"2022","unstructured":"Shearer D, Young S, Fairbairn N, Brar R. Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series. Drug Alcohol Rev. 2022;41(2):444\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"1116_CR13","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","volume":"16","author":"NB Varshneya","year":"2022","unstructured":"Varshneya NB, Thakrar AP, Hobelmann JG, Dunn KE, Huhn AS. Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl. J Addict Med. 2022;16(4):e265\u20138.","journal-title":"J Addict Med"},{"issue":"7","key":"1116_CR14","first-page":"99","volume":"20","author":"R H\u00e4mmig","year":"2016","unstructured":"H\u00e4mmig R, Kemter A, Strasser J, von Bardeleben U, Gugger B, Walter M, et al. Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method. Subst Abuse Rehabil. 2016;20(7):99\u2013105.","journal-title":"Subst Abuse Rehabil"},{"issue":"4","key":"1116_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/08897077.2021.1915914","volume":"42","author":"JP DeWeese","year":"2021","unstructured":"DeWeese JP, Krenz JR, Wakeman SE, Peckham AM. Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: titration, implementation barriers, and strategies to overcomes. Subst Abuse. 2021;42(4):506\u201311.","journal-title":"Subst Abuse"},{"key":"1116_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13722-020-0177-x","volume":"15","author":"J Rozylo","year":"2020","unstructured":"Rozylo J, Mitchell K, Nikoo M, Durante SE, Barbic SP, Lin D, et al. Case report: successful induction of buprenorphine\/naloxone using a microdosing schedule and assertive outreach. Addict Sci Clin Pract. 2020;15:2.","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"1116_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/15563650.2022.2028802","volume":"60","author":"K Baumgartner","year":"2022","unstructured":"Baumgartner K, Salmo E, Liss D, Devgun J, Mullins M, Galati B, et al. Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study. Clin Toxicol Phila Pa. 2022;60(6):688\u201393.","journal-title":"Clin Toxicol Phila Pa"},{"issue":"6","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/emp2.12289","volume":"1","author":"J Moe","year":"2020","unstructured":"Moe J, Badke K, Pratt M, Cho RY, Azar P, Flemming H, et al. Microdosing and standard-dosing take-home buprenorphine from the emergency department: a feasibility study. J Am Coll Emerg Physicians Open. 2020;1(6):1712\u201322.","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"1","key":"1116_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13722-021-00220-2","volume":"16","author":"JSH Wong","year":"2021","unstructured":"Wong JSH, Nikoo M, Westenberg JN, Suen JG, Wong JYC, Krausz RM, et al. Comparing rapid micro-induction and standard induction of buprenorphine\/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial. Addict Sci Clin Pract. 2021;16(1):11.","journal-title":"Addict Sci Clin Pract"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01116-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-023-01116-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01116-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T10:14:37Z","timestamp":1685528077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-023-01116-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s11916-023-01116-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"14 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This narrative review did not require consent from subjects or review by an institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}